Skip to content
sellNotable cluster of 4

Meade Christopher J. sold $19M of BLK

General Counsel and CLO at BlackRock, Inc.. 18,000 shares at an average of $1,045.83, traded Dec 6, 2024, filed Dec 6, 2024.

Warning score
60
Value
$19M
18,000 shares
Holdings after
8,628
-68% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001127602-24-028812, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 6, 2024MOption exercise
Common Stock
+18,000$513.50$9.2M26,628Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-2,760$1,041.96$2.9M23,868Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-1,728$1,042.64$1.8M22,140Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-1,974$1,043.79$2.1M20,166Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-1,630$1,044.88$1.7M18,536Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-2,654$1,046.20$2.8M15,882Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-1,761$1,047.33$1.8M14,121Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-2,200$1,048.18$2.3M11,921Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-700$1,049.01$734k11,221Dec 6, 2024
Dec 6, 2024SOpen-market sale
Common Stock
-2,593$1,050.00$2.7M8,628Dec 6, 2024
Dec 6, 2024GGift
Common Stock
-192$0.00$08,436Dec 6, 2024
Dec 6, 2024MOption exercise
Employee Stock Option (Right to Buy)derivative
-18,000$0.00$018,095Dec 6, 2024

Related signals

Other insiders at BlackRock, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
70Notablesell 4BLK
BlackRock, Inc.
FINK LAURENCE
Chairman and CEO
$50M48,700
65Notablesell 4BLK
BlackRock, Inc.
Goldstein Robert L.
Chief Operating Officer
$56M54,000
60Notablesell 4BLK
BlackRock, Inc.
Wiedman Mark
Senior Managing Director
$38M36,190

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.